Could a Patient's own blood and fat build a better breast after cancer surgery?

NCT ID NCT07658170

Recruiting now Disease control Sponsor: The Leningrad Regional Clinical Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tests a new approach to breast reconstruction after cancer surgery. Doctors take a patient's own fat and mix it with a substance made from their blood (platelet-rich fibrin) to create a 'lipobolus' that fills the gap left by tumor removal. The goal is to see how much of the graft survives after radiation therapy and whether the procedure is safe. The study involves 30 women with early-stage breast cancer who will be followed for 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Lipobolus (autologous fat mixed with platelet-rich fibrin and calcium chloride)
What this could lead to: If successful, this approach could offer a safer, more natural way to reconstruct breast shape immediately after cancer surgery, potentially improving cosmetic outcomes and patient satisfaction.
What could go wrong: This is a small, early-phase study with only 30 participants, so results may not apply to everyone. Risks include graft failure, infection, or interference with cancer treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER FAT GRAFT LIPOFILLING PLATELET RICH PLASMA

Contacts and locations

Locations

Leningrad Regional Clinical Hospital
RECRUITING

Saint Petersburg, 188663, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.